A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

NCT07579949 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Thalassemia

Interventions

DRUG: SNH-119014 dose 1
DRUG: SNH-119014 dose 2
DRUG: Placebo

Sponsor

ScinnoHub Pharmaceutical Co., Ltd.